Takara Holdings×Kidswell Bio
Different ways of making money, on the same scale.
Same yardstick
| Metric | Takara HoldingsFY ending Mar 2026 | Kidswell BioFY ending Mar 2026 |
|---|---|---|
| Revenue | ¥394.3B | ¥6.59B |
| COGS ratio | 67.6% | 73.5% |
| Operating margin | 4.3% | -2.1% |
| Net margin | 3.0% | -6.3% |
| FCF margin | -1.2% | -16.9% |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- Takara HoldingsPrimary industry: Alcoholic Beverages
- Kidswell BioPrimary industry: Biotech & Regenerative Medicine
CompanyRank
Revenue growth
- Takara Holdings64.37 peers
- Kidswell BioN/A
- Takara Holdings
Profitability
- Takara Holdings7.17 peers
- Kidswell Bio256 peers
- Takara Holdings
Cash conversion
- Takara Holdings507 peers
- Kidswell BioN/A
- Takara Holdings
Efficiency
- Takara Holdings78.67 peers
- Kidswell Bio92.97 peers
- Takara Holdings
Financial strength
- Takara HoldingsN/A
- Kidswell BioN/A
- Takara Holdings
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
Takara Holdings¥394.3B · keeps ¥4 per ¥100
Kidswell Bio¥6.59B · keeps ¥-2 per ¥100
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.